Position in RPRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$37,255,516
+$5,798,036 QoQ
Shares Held
776,642
-4.6% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $182,532,224 across 11 Biotechnology names. RPRX ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,567 | $45,800,268 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
776,642 | $37,255,516 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
35,939 | $27,767,908 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,595 | $21,372,547 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
109,134 | $20,631,782 | |
| 6 | INSM |
INSMED Inc
|
90,826 | $14,851,867 | |
| 7 | INCY |
Incyte Corp
|
80,755 | $7,600,660 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
53,365 | $5,189,746 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,255,516 | 776,642 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $31,457,480 | 814,117 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $32,166,293 | 911,743 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $22,839,128 | 633,892 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $19,757,183 | 634,667 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $20,379,709 | 798,891 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $12,454,050 | 440,228 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $12,017,520 | 455,727 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $13,135,450 | 432,514 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $8,225,032 | 292,810 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $7,468,738 | 275,193 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $9,948,355 | 323,629 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $13,468,914 | 373,825 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $8,715,227 | 220,527 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $1,223,119 | 30,441 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $1,196,080 | 28,451 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $931,144 | 23,900 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $897,501 | 22,522 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $505,598 | 13,990 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $218,066 | 5,320 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $232,058 | 5,320 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||